Qiagen launches new QIAsymphony automated lab instrument
This article was originally published in Clinica
Executive Summary
Qiagen has launched the QIAsymphony AS, the latest model in the QIAsymphony series of automated systems for molecular biology labs. The new instrument provides fully-automated set-up of Qiagen’s assays and PCR kits, and simplifies routine work processes. The device follows the QIAsymphony SP, a sample purification system that Qiagen launched in 2008 (www.clinica.co.uk, July 1 2008). The Dutch firm says that the new device “extends the capabilities of the QIAsymphony SP”, while featuring the same easy-to-use software. Samples processed by the QIAsymphony SP can be automatically transferred to the QIAsymphony AS, reducing handling steps and freeing up time.
You may also be interested in...
What are the hottest innovations from Israel?
Israel is well-known as a medtech hot-spot, with a focus on academic research and strong government support helping the country punch well above its weight when it comes to innovative devices.
EuroPCR: St Jude and Philips talk up rival intravascular imaging techs
St Jude Medical had a heavy focus on its intravascular imaging offering at this year’s EuroPCR meeting, presenting data supporting its optical coherence tomography (OCT) technology. OCT provides intravascular images to help assess culprit lesions, which can improve stent selection and deployment, according to St Jude.
EuroPCR: Medtronic's drug-coated balloon keeps rising
A big topic at this year’s EuroPCR, held in Paris on 19-22 May, was drug-coated balloons (DCBs). One of the leaders in the field, Medtronic, presented positive data from two studies of its IN.PACT Admiral balloon, which could support an expanded indication for the device.